DEI Biopharma is expected to produce all of the biologic medicines listed as essential drugs
Getting your Trinity Audio player ready...
MATUGGA – Dei Biopharma is awaiting approval of the World Health Organisation (WHO) to out it's Molnupiravir drug, which will be the first such product to treat Covid-19 infection in the world.DEI Biopharma has also laid out the plans for other essential newer products — including Paxlovid, Fluvoxamine, Ritonavir, Nirmatrelvir, and Rilpivirine.The development was announced by DEI Group Managin

Thank You For Reading CEO East Africa Magazine.

Please SUBSCRIBE for UNLIMITED ACCESS to our game-changing stories or LOG IN for existing members.

Tagged: